Cargando…
PSME4 Degrades Acetylated YAP1 in the Nucleus of Mesenchymal Stem Cells
Intensive research has focused on minimizing the infarct area and stimulating endogenous regeneration after myocardial infarction. Our group previously elucidated that apicidin, a histone deacetylase (HDAC) inhibitor, robustly accelerates the cardiac commitment of naïve mesenchymal stem cells (MSCs)...
Autores principales: | Kim, Yong Sook, Kim, Mira, Cho, Dong Im, Lim, Soo Yeon, Jun, Ju Hee, Kim, Mi Ra, Kang, Bo Gyeong, Eom, Gwang Hyeon, Kang, Gaeun, Yoon, Somy, Ahn, Youngkeun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415559/ https://www.ncbi.nlm.nih.gov/pubmed/36015285 http://dx.doi.org/10.3390/pharmaceutics14081659 |
Ejemplares similares
-
PSME4 determines mesenchymal stem cell fate towards cardiac commitment through YAP1 degradation
por: Kim, Mira, et al.
Publicado: (2023) -
HDAC Inhibitors: Therapeutic Potential in Fibrosis-Associated Human Diseases
por: Yoon, Somy, et al.
Publicado: (2019) -
Nitrosative Stress and Human Disease: Therapeutic Potential of Denitrosylation
por: Yoon, Somy, et al.
Publicado: (2021) -
Serum Ferritin as a Diagnostic Biomarker for Kawasaki Disease
por: Kim, Sung Hoon, et al.
Publicado: (2021) -
SUMOylation-mediated PSME3-20S proteasomal degradation of transcription factor CP2c is crucial for cell cycle progression
por: Son, Seung Han, et al.
Publicado: (2023)